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Vascular calciﬁcation shares many similarities with skeletal mineralisation and involves the phenotypic trans-differentiation of vascular
smooth muscle cells (VSMCs) to osteoblastic cells within a calciﬁed environment. Various microRNAs (miRs) are known to regulate cell
differentiation; however, their role in mediating VSMC calciﬁcation is not fully understood. miR-microarray analysis revealed the signif-
icant down-regulation of a range of miRs following nine days in culture, including miR-199b, miR-29a, miR-221, miR-222 and miR-31
(p< 0.05). Subsequent studies investigated the speciﬁc role of the miR-221/222 family in VSMC calciﬁcation. Real-time quantitative
polymerase chain reaction data conﬁrmed the down-regulation of miR-221 (32.4%; p< 0.01) and miR-222 (15.7%; p< 0.05). VSMCs
were transfected with mimics of miR-221 and miR-222, individually and in combination. Increased calcium deposition was observed
in the combined treatment (two-fold; p< 0.05) but not in individual treatments. Runx2 and Msx2 expression was increased during calci-
ﬁcation, but no difference in expression was observed following transfection with miR mimics. Interestingly, miR-221 and miR-222
mimics induced signiﬁcant changes in ectonucleotide phosphodiesterase 1 (Enpp1) and Pit-1 expression, suggesting that these miRs
may modulate VSMC calciﬁcation through cellular inorganic phosphate and pyrophosphate levels. © 2013 The Authors. Cell Biochemistry
and Function published by John Wiley & Sons, Ltd.
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INTRODUCTION
The pathological deposition of calcium phosphate min-
eral, most often hydroxyapatite, in arteries and cardiac
valves has severe clinical consequences and is considered
as an accurate predictor of future adverse cardiovascular
events. Extensive research has shown that this vascular
calciﬁcation is a tightly regulated process that shares
many similarities with physiological bone mineralisation.
Certainly, the trans-differentiation of vascular smooth
muscle cells (VSMCs) into an osteo/chondrogenic pheno-
type has been deﬁned, and along with subsequent changes
in gene expression, this is thought to be the main media-
tor of vascular calciﬁcation. However, the precise mecha-
nisms underlying the initiation and progression of
pathological vascular calciﬁcation have yet to be fully
determined.
MicroRNAs (miR) are an important class of endogenous,
single stranded, non-coding RNAs, which are involved in
the regulation of gene expression and translation, and as
such, miRs are important in regulating cellular differentia-
tion. This novel class of gene regulators are still however
poorly understood; although more than 400 human miRs
have been cloned, the biological functions of only a small
portion have been characterized.1,2 miRs are important in
the development, proliferation and function of VSMCs,
and recent studies have deﬁned a direct involvement of
miRs in pathological calciﬁcation.3–7
In this study, we sought to establish which miRs are
differentially regulated during the trans-differentiation and
subsequent calciﬁcation of murine VSMCs through microar-
ray analysis. We conﬁrm that similar changes in miR
expression identiﬁed in the microarray data can be detected
by real-time quantitative polymerase chain reaction (RT-
qPCR). We identify miR-221 and miR-222 as potentially
important regulators of calciﬁcation, and as such, we
transfected VSMCs with mimics of miR-221 and miR-222
revealing an increase in calcium deposition with concomi-
tant changes in known regulators of mineralisation. Finally
and somewhat surprisingly, we show that the effect of
miR-221/222 was independent of the transcription factors
Runx2 and Msx2.
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MATERIALS AND METHODS
Primary murine vascular smooth muscle cells isolation
and maintenance
Primary VSMCs were isolated from 5-week old wild-type
male C57BL/6 mice as previously described.8 Brieﬂy, after
removal of adventitia, the aorta was cut open to expose the
endothelial layer. Tissues from 16 animals were pooled for
digestion with 1mg/ml trypsin for 10min in order to remove
any remaining adventitia and endothelium. Following a
further overnight incubation at 37 °C in a humidiﬁed atmo-
sphere of 95% air/5% CO2 in growth medium (α-MEM
(Invitrogen, Paisley, UK) supplemented with 10% fetal
bovine serum (Invitrogen) and 1% gentamicin (Invitrogen)),
tissues were then digested with 425U/ml collagenase type II
(Worthington Biochemical Corporation, Lakewood, USA) for
5 h. Isolated VSMCs were expanded in growth medium for
two passages in T25 tissue culture ﬂasks (Greiner Bio-one,
GmbH, Frickenhausen, Baden-Wurttemberg, Germany) coated
with 0.25μg/cm2 murine laminin (Sigma, Poole, UK) to
promote maintenance of the contractile differentiation state.9
Calciﬁcation of vascular smooth muscle cells for global miR
expression analysis
Primary VSMCswere seeded in growth medium at a density of
1.5×104/cm2 in multi-well plates (Corning Costar, MA, USA).
At conﬂuency (day 0), VSMCs were cultured in growth
medium supplemented with 2.5mM β-glycerophosphate
(Sigma) and 50μg/ml ascorbic acid (Sigma) to induce VSMC
trans-differentiation and calciﬁcation as previously shown.10,11
RNA was extracted at day 9 of culture using the mirVana kit
(Invitrogen) according to manufacturer’s instructions.
Affymetrix miR labelling, array hybridization and
data processing
RNA quality was assessed by using the Agilent model 2100
bioanalyzer (Agilent Technologies, Palo Alto, CA). Only
samples with intact, distinct ribosomal peaks were chosen
for further analysis. Two micrograms of total RNA was
processed for the microarray by using the Affymetrix ﬂashtag
RNA labelling kit (Affymetrix, Santa Clara, CA, USA)
according to the manufacturer’s recommended protocols by
adding 2μg total RNA to the tailing reaction (2.5mMMnCl2,
ATP and poly(A) polymerase) with incubation for 15mins at
37 °C. This was followed by ligation of the biotinylated signal
molecule to the target RNA sample (1× ﬂash tag ligation mix
biotin, T4 DNA ligase).
Each sample was hybridized to a GeneChip® miR array
(Affymetrix) at 48 °C for 16 h. The arrays were washed,
stained and scanned using the Affymetrix model 450 ﬂuidics
station and Affymetrix model 3000 scanner using the manu-
facturer’s recommended protocols.
The image data were analysed with the miR quality
control tool software for quality control software. Further
analysis was performed using the GENESPRING GX10 soft-
ware (Agilent Technologies, USA). The expression values
were summarized and normalized respectively with robust
multi-array average and variance stabilization method using
robust multi-array average and variance stabilization method
packages from Bioconductor 2.5.
Transfection of microRNAs with microRNA mimics and
culture under high phosphate conditions
Primary VSMCs were seeded in growth medium at a density
of 1.5 × 104/cm2 in multi-well plates (Corning Costar).
Immediately, following seeding cells were transfected with
100 nMmiScript miR mimics, in combination or individually,
(miR-221: 5’AGCUACAUUGUCUGCUGGGUUUC3’;
miR-222: 5’AGCUACAUCUGGCUACUGGGU3’ and
undisclosed Allstars negative control – Qiagen, West Sussex,
UK) that had been complexed in 5μl HiPerfect transfection
reagent (Qiagen) and 45μl Opti-Mem. medium (Invitrogen)
for 20mins. After 24 h, cells were cultured in control or high
inorganic phosphate (Pi) medium (α-minimal essential
medium supplemented with 10% fetal calf serum, 1%
gentamycin and 2mM Na2HPO4/NaH2PO4 pH7.4), which
we have previously shown to induce calciﬁcation after 7 days
in culture.11 At day 3 in high Pi medium, the medium was
changed and a repeat transfection mix was added to the
fresh medium.
Analysis of gene expression using quantitative real-time
quantitative polymerase chain reaction
RNA was extracted from transfected cells using the RNeasy
total RNA kit (Qiagen) or miRNeasy mini kit (Qiagen),
according to the manufacturer’s instructions at days 0, 3 and
7 of culture. For each sample, total RNA content was assessed
by absorbance at 260 nm and purity by A260/A280 ratios.
RNA was reverse transcribed using superscript II (Invitrogen)
for total RNA and miRScript reverse transcriptase for miR
preparations. Quantitative PCR (RT-qPCR) was performed
using FastStart Sybr Green (Roche, East Sussex, UK) for total
RNA and miScript Sybr Green PCR kit (Qiagen) on the
Stratagene Mx3000P real-time RT-qPCR system (Stratagene,
CA, USA).12,13 Primers for Runx2 (forward, 5ACCATAA-
CAGTCTTCACAAATCCT3; reverse, 5CAGGCGATCA-
GAGAACAAACTA3), Pit-1 (forward, 5’CACTCATGTC-
CATCTCAGACT3’; reverse, 5’CGTGCCAAAGAAGGT-
GAAC3’) and ectonucleotide phosphodiesterase (Enpp1)
(forward: 5’GCTAATCATCAGGA-GGTCAAG3’; reverse,
5’CTGGTAGAATCCCGTCA-ATC3’) were purchased from
Primer Design (Southampton, UK). Sequences of Primers
used to detect expression of Gapdh (Primer Design), Msx2
(Qiagen Ltd) and all miRs (Qiagen) were not disclosed by
the manufacturer.
Detection of calciﬁcation
The matrix was decalciﬁed in 0.6N HCL for 24 h, and free
calcium determined colorimetrically using a commercially
available kit (Randox Laboratories Ltd, County Antrim, UK)
and corrected for total protein content measured using the
Bio-Rad protein assay reagent (Bio-Rad Laboratories,
Hertfordshire, UK). Gamma globulin was used as standard.14
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Statistical analysis
Data are presented as the means ± SEM. Statistical analysis
was determined by the general linear model analysis incor-
porating pairwise comparisons and the student t-test using
Minitab 15 (Minitab Inc, Coventry, UK). p< 0.05 was con-
sidered to be signiﬁcant.
RESULTS
MicroRNAs regulate cellular changes during the
trans-differentiation of vascular smooth muscle cells
To determine the role of miRs in vascular calciﬁcation, we
conducted miR microarray analysis of VSMCs cultured
under calcifying conditions. This identiﬁed an extensive range
of miRs differentially expressed during the trans-differen-
tation of murine VSMCs in culture (>100), the most signiﬁ-
cant of which are detailed in Table 1. To conﬁrm our
microarray data, a selection of miRs was chosen for RT-qPCR
validation. In agreement with the results of the microarray,
these data indicated signiﬁcant down-regulation of miR-221
(32.4%; p< 0.01), miR-222 (15.7%; p< 0.05), miR-24-2
(23.7%; p< 0.01), miR-27a (30%; p< 0.01), miR-31
(43.7%; p< 0.01) and miR-199b (13.6%; p< 0.05) expres-
sion in VSMC cells cultured for 14 days compared with 7 days
in high Pi medium in culture (Figure 1A–F). Given that medial
vascular calciﬁcation in humans is associated with high
circulating phosphate levels, VSMCs were treated in a
medium containing high Pi, which we have previously
shown to induce calciﬁcation in vitro.11 All miRs examined
were also signiﬁcantly down-regulated when cultured in
high Pi medium in comparison with VSMCs cultured in
control medium, apart from miR-199b (p< 0.05,
Figure 1A–E), although the magnitude of change was consid-
erably lower than the microarray study.
miR-221 and miR-222 synergistically act to promote
vascular smooth muscle cells calciﬁcation
Our microarray and RT-qPCR data conﬁrmed that miR-221
and miR-222 are down-regulated during the calciﬁcation of
murine VSMCs (Figure 1A and B). Because of the known
roles of miR-221 and miR-222 in the cell cycle,15,16 we next
sought to examine their functional role in VSMC calciﬁcation
in vitro. We transfected VSMCs with mimics of miR-221
(50 nM) and miR-222 (50 nM), individually and in combina-
tion, alongside a miR-ve control transfection. All cell cultures
showed time-dependent increases in calcium deposition after
7 days of treatment in comparison with days 0 and 3 of culture
as expected (Figure 2A). Calcium deposition in VSMCs
co-transfected with the combination of both miR-221 and
miR-222 was signiﬁcantly increased in comparison with those
transfected with miR-ve (two-fold; p< 0.05, Figure 2A).
Interestingly, cells transfected with individual miR-221 and
miR-222 mimics did not show any signiﬁcant differences
when compared with the miR-ve treated cells (Figure 2A).
These data suggest that the synergistic actions of miR-221
and miR-222 alter the trans-differentiation of VSMCs and
increase the rate of calciﬁcation in vitro, which is not seen
upon individual action.
miR-221/222-induced VSMC calciﬁcation is independent of
Runx2 and Msx2
The transcription factors Runx2 and Msx2 are pivotal in bone
mineralisation; we and others have previously shown that
Runx2 is critical during the trans-differentiation of VSMCs
under high phosphate conditions.11,17,18 Therefore to examine
whether miR-221 and miR-222 act through these trans-
cription factors, VSMCs were treated with miR-221 and
miR-222, in combination and individually, and were exam-
ined for Runx2 mRNA expression by RT-qPCR. Here,
we found a signiﬁcant increase in Runx2 mRNA expres-
sion in all VSMC cells following 3 days in high phosphate
medium (in comparison with day 0, p< 0.001, Figure 2B).
However, no signiﬁcant differences were observed when
the different combinations of miR treatments were consid-
ered (Figure 2B). Similarly, the osteogenic transcription
factor Msx2, also showed increased mRNA expression at
Table 1. MicroRNAs differentially expressed during the in vitro
calciﬁcation of murine aortic VSMCs as analysed by microarray analysis
Down-regulated
miRNA Fold change
miR-379 222.5
miR-199b 269.8
let-7i 238
miR-16 192.5
miR-27b 195.1
miR-29a 168.2
miR-221 108.6
miR-199a 102.4
miR-674 139.2
miR-151 81.2
miR-100 95.3
miR-222 80.9
miR-22 90.3
miR-652 83.2
miR-130a 77.8
miR-382 69.7
miR-361 69.4
miR-27a 48.2
miR-24-2 43.8
miR-31 40.6
Up-regulated
miR-706 19.3
miR-714 17.6
miR-1192 15.6
miR-487-b 8
miR-376b 9.7
miR-702 7.9
miR-703 6.8
miR-483 4.8
miR-208b 3.5
miR-759 3.1
Table shows those microRNAs that are signiﬁcantly down-regulated or up-
regulated after 9 days in calcifying culture medium when compared with
day 0. Highlighted in bold are those selected for further examination.
miR, microRNAs.
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day 3 of VSMC culture. However, no signiﬁcant differences
were observed between cells treated with miR-221/222 in
combination and cells treated with miR-ve (Figure 2C). These
data suggest that the synergistic function of miR-221 and
miR-222 in promoting vascular calciﬁcation is independent
of Runx2 and Msx2.
Altered expression of phosphate regulators by miR221/222
Further studies examined the expression proﬁle of Enpp1,
which regulates vascular calciﬁcation through the generation
of the mineralization inhibitor pyrophosphate (PPi).
19,20
Twenty-four hours following transfection, prior to treatment
with high phosphate medium (day 0), a signiﬁcant increase
in Enpp1 mRNA expression in VSMCs transfected with
either miR-221 or miR-222 was observed when compared
with miR-ve transfected cultures (Figure 3A, p< 0.001). In
contrast, VSMCs transfected with both miR-221/222
showed no signiﬁcant differences in comparison with miR-
ve transfected cultures (Figure 3A). These ﬁndings may offer
some explanation to the differences in VSMC calciﬁcation
observed between individual and combined transfection.
Furthermore, in control cells transfected with miR-ve, there
was a signiﬁcant increase in expression of type III sodium-
dependent Pi cotransporter-1 (Pit-1) on day 7 of culture in
high phosphate medium, as previously reported in studies
from this group.10 These increases were not observed in
VSMCs transfected with miR-221 and/or miR-222
(Figure 3B, p< 0.001). Taken together, these data indicate
that the miR-221 and miR-222 may lead to changes in the
cellular balance of Pi and PPi through altered Enpp1 and
Pit-1 expressions.
A B
D
F
C
E
Figure 1. Down-regulation of microRNA expression during the in vitro calciﬁcation of murine aortic VSMCs cultured for 14 days with 3mM Pi (high
phosphate medium) in comparison with control medium. Fold change in the mRNA expression of (A) miR-221, (B) miR-222, (C) miR-24-2, (D) miR-27a,
(E) miR-31 and (F) miR-199b. Results are presented as mean±SEM, a) p< 0.01** versus day 7, b) p< 0.05* versus day 7, c) p< 0.01** versus control medium
and d) p< 0.05* versus control medium
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DISCUSSION
Despite recent advances in our knowledge, the full
mechanisms underpinning vascular calciﬁcation have yet to
be fully elucidated. This study has clearly demonstrated
differential expression of novel miRNAs in murine primary
vascular smooth muscle cell cultures, cultured under calcify-
ing conditions. Of note, a wide range of miRs associated with
cell proliferation, differentiation and oncogenesis has been
shown to be down-regulated through microarray analysis.
We selected a small number of miRNAs and use RT-qPCR
to conﬁrm their down-regulation in VSMCs under high phos-
phate culture conditions, designed to mimic high levels of
circulating phosphate associated with medial calciﬁcation.21
These data conﬁrm the signiﬁcant down-regulation of miR-
221, miR-222, miR-24-2, miR-27a and miR-31 during
in vitro vascular calciﬁcation. The differences observed
between the magnitude of down-regulation in the microarray
and RT-qPCR studies are likely due to the different methods
of analysis and normalization tools used.
A number of miRs associated with VSMC calciﬁcation in
the present study have previously been implicated in cancer
development.22–25 In particular, miR-24-2 and mir-27a have
been shown to constitute a cluster, along with miR-23a, which
has known roles in the promotion of cell differentiation in
several cancers.26,27 More recently, this cluster has also been
Figure 2. The effect of miR-221 and miR-222 transfections on the in vitro calciﬁcation of murine aortic VSMCs cultured for up to 7 days in high phosphate
medium (3mM Pi). (A) Calcium content was determined by quantiﬁcation of HCl leaching (microgram/milligramme protein) at days 3 and 7 of culture in
comparison with day 0. Fold change in the mRNA expression of (B) Runx2 (C) Msx2. Results are expressed as mean±SEM, a) p< 0.05* versus miR-ve, b)
p< 0.001*** versus day 0 and c) p< 0.05* versus day 0
Figure 3. Changes in mRNA expression of known markers of VSMC calciﬁcation upon transfection with miR-221 and miR-222. Fold change in the mRNA
expression of (A) Enpp1 (B) Pit-1. Results are expressed as mean ±SEM a) p< 0.001*** versus miR-ve, b) p< 0.001*** versus day 0, c) p< 0.001*** versus
day 3
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implicated in the repression of genes involved in the inhibition
of bone formation. Both a feed-forward mechanism by which
Runx2 acts to suppress this cluster and in turn prevent their
inhibitory effects on bone formation and a feedback mecha-
nism by which miR-23a directly inhibits Runx2 expression
have recently been reported.28 This therefore suggests that this
miR cluster acts to inhibit the differentiation of the osteoblast
into an osteocyte. The similarities between osteoblast matrix
mineralisation and VSMC calciﬁcation, as well as the known
trans-differentiation of the VSMC into an osteoblast/osteocyte
phenotype,10 are therefore consistent with the down-regulation
of this cluster during the vascular calciﬁcation process.
We have also conﬁrmed the down-regulation of miR-31
during in vitro VSMC calciﬁcation, which too has been
implicated in the inhibition of osteogenic differentiation.
Microarray analysis of differentiating mesenchymal stromal
cells has recently highlighted a potent functional role for
miR-31, involving the inhibition of tissue non-speciﬁc
alkaline phosphatase (TNAP) activity through a mechanism
dependent on Runx2 and Bmp2.29 Comparable ﬁndings have
also been recently observed in bone marrow stromal cells
and in the trans-differentiation of the VSMC phenotype
through the cellular repressor of E1A-stimulated genes.30–32
Additionally, miR-31 has been shown to be increased in the
serum of patients with coronary artery disease, which present
with severe vascular calciﬁcation.30 This report of miR-31 as a
potential biomarker in a disease involving VSMC phenotype
modulation is likely to have major clinical beneﬁt. These
clinical data highlight the potential for further miRs to be
investigated as biomarkers of vascular calciﬁcation, including
those identiﬁed in the present study.
This study presents the ﬁrst evidence to suggest that miR-
221 and miR-222 contribute to the pathological process of
vascular calciﬁcation. We have demonstrated the down-
regulation of these miRs during VSMC calciﬁcation, which
is consistent with recent microarray analysis of differentiating
mesenchymal stromal cells.29 We also reveal a novel func-
tional role for the synergistic actions of miR-221 and miR-
222 in VSMC calciﬁcation under high phosphate conditions.
Through the transfection of calcifying VSMCs with mimics
of these miRs, we show that there are no signiﬁcant changes
in Runx2 and Msx2 expressions between different miR treat-
ments. These data indicate that the increases in calciﬁcation
observed are independent of these potent transcription factors
and are consistent with the trans-differentiation of the VSMCS
to an osteoblast/osteocyte phenotype as has previously been
described.10,11,33 It is interesting to note that whilst we see a
down-regulation of miR-221 and miRNA-222 in calcifying
cells, the increase in cellular miR levels synergistically act to
increase levels of cellular calciﬁcation. We hypothesize that
these miRs may be involved in the initiation of early stages
of cellular trans-differentiation and that their expression is
reduced as the cells progress towards an osteo/chondrogenic
phenotype. This theory is supported by studies on human stem
cells showing that miR222 was up-regulated during the initia-
tion of differentiation to neuronal cells and subsequently
reduced as the cells reached adulthood,34,35 as well as recent
investigations demonstrating that the down-regulation of
miR221 induces osteogenic differentiation.36 Further studies
into the effects of these miRs on VSMCs cultured under low
phosphate conditions may provide new insights into their role
during the initiation of differentiation.
Furthermore, we have shown that miR-221 and miR-222
may regulate the cellular balance of Pi and PPi through altered
Enpp1 and Pit-1 expression. This suggests a mechanism
through which these miRs may regulate VSMC trans-
differentiation and calciﬁcation. This is supported by recent
studies, which have highlighted these molecules as key
regulators of vascular calciﬁcation.10,20,21,37 Our data show
that the initial transfection with individual miRNAs induces
an increase in Enpp1 expression at day 0 (24 h after trans-
fection), which is subsequently reduced following the wide-
spread changes in gene expression seen following high Pi
treatment.11,37 It is likely that these changes in Enpp1 expres-
sion at day 0 are due to the trans-differentiation of cells
towards an osteogenic phenotype and associated changes in
gene expression. Interestingly, the increase of Enpp1 expres-
sion is not observed in the combined miR-221/miR-222
treatments, which may give an explanation as to the higher
level of calciﬁcation seen in these cells and suggests that the
changes in gene expression may be regulated by upstream
pathways. Indeed, we have found no apparent evidence of
miR-221 or miR-222 directly targeting any of the known
regulators of cellular Pi/PPi concentrations such as Enpp1,
Alpl, Ank, Pit-1 and Phospho1.20,37 In fact, the previously
documented promotion of vascular calciﬁcation by Pit-1
suggests that the effects we are seeing here are not due to
direct increases in Pit-1 per se.38 It is conceivable that the
changes in Enpp1 and Pit-1 observed in this study are a result
of upstream changes in cell cycle progression mediated by
transfection of cells with miR-221 and/or miR222, with com-
bined miRNAs acting on a wider range of pathways than the
individual miRNAs. It has recently been shown that induction
of the cAMP/protein kinase A pathway signiﬁcantly alters the
expression of Enpp1, ANK and TNAP during phosphate
induced calciﬁcation.39 Further studies into the pathways lead-
ing to changes in NPP1 and Pit-1 and subsequent effects on
the cellular and extracellular levels of Pi and PPi, would be
very revealing. It would also be of interest to expand these
investigations to additional regulators of production, transport
and degradation of Pi/PPi.
miR-221 and miR-222 have been previously described as
regulators of cell cycle progression via p21, p27kip1 and
p57 kip2 in various human cancers.15,16,40,41 Furthermore,
they have been implicated in tumour necrosis factor-related
apoptosis-inducing ligand (TRAIL) resistance in lung cancer
cell lines through interfering with p27kip1, phosphatase and
tensin homology and tissue inhibitors of metalloproteinases
expressions.41–43 Consistent with their role in cancer cells,
miR-221 and miR-222 have been shown to have pro-
proliferative, pro-migratory and anti-apoptotic effects that
effect on cultured VSMCs.44 This increase in proliferation
has been partially attributed to changes in p27(kip1) and p57
(kip2); however, the full effects of these miRs in VSMCs have
yet to be fully determined. miR-221 has also been shown to
regulate chondrogenic differentiation by targeting Mdm2,
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further highlighting the potential importance of these miRs in
the calciﬁcation process.45
In conclusion, we have established that miR-221 and miR-
222 work concomitantly to alter the trans-differentiation of
murine VSMCs and promote calciﬁcation in vitro. We iden-
tify a potential mechanism of action through the calciﬁca-
tion regulators Enpp1 and Pit-1. These data will provide
advances towards clinical beneﬁt by offering a greater un-
derstanding of the molecular mechanisms underpinning
vascular calciﬁcation, an acute predictor of future adverse
cardiovascular events.
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